The COVID-19 pandemic has dramatically impacted clinical practice due to staff redeployment, reduced face-to-face patient contact and the temporary closure of routine services1 . Consequently, this has had a negative …
Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy agents: a meta-analysis.
Hand-foot syndrome (HFS) is a common systemic skin toxicity syndrome caused by chemotherapy agents. However, there is no uniform clinical treatment for HFS. It is reported that pyridoxine (vitamin B6) …
Molecular epidemiology of pachyonychia congenita in the Israeli population.
Pachyonychia congenita (PC) is a rare autosomal dominant disorder featuring palmoplantar keratoderma, nail dystrophy, oral leukokeratosis, pilosebaceous cysts and natal teeth. PC results from dominant mutations in one of five …
Clinical characteristics and histopathological changes of morphea: A single-center, retrospective study of 137 patients.
The clinicopathologic correlations and prognostic risk factors for refractory disease in morphea (localized scleroderma) are poorly described.To investigate the association between clinical characteristics and histopathological features of morphea and identify …
Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 can be Divided Into Inflammatory and Vascular Patterns.
This review examines the clinical, morphological, and systemic factors related to coronavirus disease 2019 (COVID-19) cutaneous manifestations. The EMBASE, Medline, and Pubmed Central databases were searched from February 1, 2020 …
Cutaneous eruption in COVID-19-infected patients in Thailand: An observational descriptive study.
Coronavirus disease 2019 (COVID-19) emerged in Thailand in January 2020. Thailand was the first to report a confirmed case outside China. Cutaneous eruption in COVID-19 has been reported since the …
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
The Harmonising Outcome Measures for Eczema (HOME) initiative has established a core outcome set of domains for atopic eczema clinical trials. Previous consensus meetings have agreed upon preferred instruments for …
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial: a critical appraisal.
Vitiligo is an acquired condition which presents as cutaneous depigmentation. There is no licensed treatment for the re-pigmentation of vitiligo lesions, however, several therapies are used routinely and have been …
Scoping the international impact from four independent national dermatology trials.
Research impact describes whether and how research results in wider benefits to society beyond academic publication. Little is known about translation of clinical trial research into dermatological practice .We scoped …
Neuroimaging in infants and children in select neurocutaneous disorders.
The role of neuroimaging in neurocutaneous disorders is an evolving field. Research can be inconsistent and inconclusive, leading to divergent practice for some disorders. This study provides an overview of …